Table 3. The odds ratios for developing new-onset DM, metabolic syndrome, dyslipidemia, or hypertension within the four-year period adjusting for age and gender.
| PFAA index 1 | p value | PFAA index 2 | p value | |
|---|---|---|---|---|
| The index as a continuous variable Per SD increment | ||||
| DM | 2.06 (1.70–2.50) | <.0001 | 1.77 (1.50–2.10) | <.0001 |
| Metabolic syndrome | 3.04 (2.57–3.63) | <.0001 | 2.27 (1.96–2.64) | <.0001 |
| Dyslipidemia | 1.98 (1.74–2.26) | <.0001 | 1.74 (1.54–1.97) | <.0001 |
| Hypertension | 1.42 (1.25–1.61) | <.0001 | 1.31 (1.17–1.47) | <.0001 |
| The index as a categorical variableDM | ||||
| First quartile | 1.00 (referent) | 1.00 (referent) | ||
| Second quartile | 2.39 (1.18–5.25) | 0.0150 | 2.08 (1.08–4.28) | 0.0281 |
| Third quartile | 4.45 (2.26–9.62) | <.0001 | 2.99 (1.59–6.06) | 0.0004 |
| Fourth quartile | 6.85 (3.48–14.87) | <.0001 | 4.96 (2.66–10.01) | <.0001 |
| Metabolic syndrome | ||||
| First quartile | 1.00 (referent) | 1.00 (referent) | ||
| Second quartile | 3.37 (1.55–8.40) | 0.0014 | 4.18 (2.12–9.23) | <.0001 |
| Third quartile | 9.31 (4.50–22.61) | <.0001 | 6.95 (3.61–15.11) | <.0001 |
| Fourth quartile | 19.70 (9.56–47.75) | <.0001 | 14.58 (7.62–31.58) | <.0001 |
| Dyslipidemia | ||||
| First quartile | 1.00 (referent) | 1.00 (referent) | ||
| Second quartile | 2.16 (1.55–3.02) | <.0001 | 1.72 (1.25–2.37) | 0.0009 |
| Third quartile | 3.03 (2.16–4.30) | <.0001 | 2.70 (1.96–3.75) | <.0001 |
| Fourth quartile | 5.25 (3.66–7.60) | <.0001 | 4.07 (2.89–5.78) | <.0001 |
| Hypertension | ||||
| First quartile | 1.00 (referent) | 1.00 (referent) | ||
| Second quartile | 1.01 (0.70–1.47) | 0.9476 | 1.34 (0.94–1.92) | 0.1062 |
| Third quartile | 1.90 (1.33–2.73) | 0.0004 | 1.71 (1.21–2.44) | 0.0025 |
| Fourth quartile | 2.29 (1.60–3.32) | <.0001 | 2.15 (1.51–3.08) | <.0001 |
Values are odds ratios (95% confidence intervals) for developing these diseases from logistic regressions adjusting for age and gender. Significant odds ratios are highlighted in bold type.